ViewRay MRI Guides Brachytherapy Planning (PhysicsWorld)
A team of clinicians at the University of Wisconsin have used a ViewRay MRI-guided radiotherapy system to perform brachytherapy planning for cervical cancer. So, what motivated the team to use the UF startup’s system to perform brachytherapy planning? And how does use of the system fit time-wise alongside its use for treatments? Writing in the […]
AxoGen CEO Karen Zaderej Named A Florida Entrepreneur of the Year (BioSpace)
As a female chief executive officer in the healthcare industry CEO Karen Zaderej often stands out in a male-dominated industry. This month she stood out for another reason – as the Ernst & Young Entrepreneur of the Year 2018 Award winner for the state of Florida in the healthcare category. Zaderej leads AxoGen, a UF […]
Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application (BusinessWire)
UF startup Exactech, a leading developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, earned the Second Place Best Clinical Podium Presentation Award for one of five new research studies presented on the company’s latest computer guidance technology for knee surgery at the International Society for Computer […]
Nematodes in Space – Pheronym Wins Grant for Eco-Friendly Pest Control for Interstellar Agriculture (EIN Newsdesk)
Pheronym, a bio-ag-tech pest control company that is a client of UF Innovate | Sid Martin Biotech and a former client of The Hub, has received the Florida-Israel Innovation Partnership Award for its nematode focused pest control solution. The $300,000 award will help the company conduct field tests of its proprietary eco-friendly solution with a […]
U of Florida and Penn Ink Licensing Deal for Gene Therapy to Treat Retinal Disease (Tech Transfer eNews Blog)
Biotech company Ophthotech Corporation has entered into an exclusive global license agreement with the University of Florida Research Foundation (UFRF) and the University of Pennsylvania (Penn) to commercialize a treatment for a disease that causes blindness. The licensed technology is an adeno-associated virus (AAV) gene therapy to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an […]
Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development (Globe Newswire)
Cannabix Technologies Inc., a UF startup developing the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, has reported that recent testing with Beta 3.0 has shown the identification and first order separation of two key metabolites of ∆9-tetrahydrocannabinol (“THC”), being 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in standards. In addition, scientists have made significant progress towards using […]
Oragenics Touts New Drug to Fight Clostridium Difficile (Proactive Investors)
New research by Sid Martin Biotech alum Oragenics Inc., now a Tampa-based clinical-stage biotech group, has uncovered a novel type of antibiotic known as a lantibiotic for the treatment of clostridium difficile, an infection causing colitis, called OG716. When golden Syrian hamsters infected with clostridium difficile were treated with the drug OG716, a variant of […]
RTI Surgical Expands Portfolio of Spine Implants to Meet Surgeon Needs and Improve Patient Outcomes (RTI Surgical)
UF startup and Sid Martin Biotech alum RTI Surgical, Inc. a global surgical implant company, announced the full commercial launch of its Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures […]
Sun BioPharma, Inc. Doses First Patients in Second Clinical Study of SBP-101 for Pancreatic Ductal Adenocarcinoma (Globe Newswire)
UF startup Sun BioPharma, Inc. and its wholly owned subsidiary, Sun BioPharma Australia Pty Ltd, a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic diseases, announced that on June 4, 2018 the first patients were enrolled in a Phase 1a/1b study of SBP-101 in combination with gemcitabine and nab-paclitaxel […]
FDA Classifies Banyan Biomarkers’ Brain Trauma Assays as Class II Devices (RAPS.org)
The US Food and Drug Administration (FDA) classified brain trauma assessment tests and endoscopic electrosurgical clip cutting systems as class II devices. Both device classifications were established via the De Novo pathway based on FDA’s review of 2016 and 2017 requests from Ovesco Endoscopy AG and UF startup Banyan Biomarkers, respectively. These in turn allow […]